These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15696439)

  • 1. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.
    Epstein M; Campese VM
    Am J Kidney Dis; 2005 Jan; 45(1):2-14. PubMed ID: 15696439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors and the kidney.
    Campese VM; Hadaya B; Chiu J
    Curr Hypertens Rep; 2005 Oct; 7(5):337-42. PubMed ID: 16157074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors and the kidney.
    Campese VM; Park J
    Kidney Int; 2007 Jun; 71(12):1215-22. PubMed ID: 17495867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?
    Campese VM; Nadim MK; Epstein M
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S11-7. PubMed ID: 15938026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statin therapy on the progression of chronic kidney disease.
    Shah S; Paparello J; Danesh FR
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
    Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
    Takemoto M; Liao JK
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and biomarkers of inflammation.
    Devaraj S; Rogers J; Jialal I
    Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of statins, beyond lipid-lowering properties.
    Mihos CG; Pineda AM; Santana O
    Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins on renal function.
    Agarwal R
    Am J Cardiol; 2006 Mar; 97(5):748-55. PubMed ID: 16490450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
    Arnaud C; Mach F
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and the kidney.
    Wheeler DC
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):579-84. PubMed ID: 9818207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic vascular protective effects of statins in perioperative medicine.
    Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
    Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and the development of atherosclerosis.
    Mizuno Y; Jacob RF; Mason RP
    J Atheroscler Thromb; 2011; 18(5):351-8. PubMed ID: 21427505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.